Back to GetFilings.com



Table of Contents



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q


     
(Mark One)    
   [X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 28, 2003

OR

     
   [  ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File No. 001-31353

EMULEX CORPORATION

(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction
of incorporation or organization)
  51-0300558
(I.R.S Employer
Identification No.)
     
3535 Harbor Boulevard
Costa Mesa, California

(Address of principal executive offices)
 
92626
(Zip Code)

(714) 662-5600
(Registrant’s telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  [X] No [  ]

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes  [X] No [  ]

As of November 5, 2003, the registrant had 82,859,725 shares of common stock outstanding.



 


TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Condensed Consolidated Balance Sheets
Condensed Consolidated Statements of Income
Condensed Consolidated Statements of Cash Flows
Notes to Condensed Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Item 4. Controls and Procedures
PART II: OTHER INFORMATION
Item 1. Legal Proceedings
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
Exhibit Index
EXHIBIT 31.A
EXHIBIT 31.B
EXHIBIT 32


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES

INDEX

           
      PAGE
     
Part I. FINANCIAL INFORMATION
       
Item 1. Financial Statements
       
 
Condensed Consolidated Balance Sheets September 28, 2003 and June 29, 2003
    2  
 
Condensed Consolidated Statements of Income Three months ended September 28, 2003, and September 29, 2002
    3  
 
Condensed Consolidated Statements of Cash Flows Three months ended September 28, 2003 and September 29, 2002
    4  
 
Notes to Condensed Consolidated Financial Statements
    5  
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
    13  
Item 3. Quantitative and Qualitative Disclosures about Market Risk
    35  
Item 4. Controls and Procedures
    36  
Part II. OTHER INFORMATION
       
Item 1. Legal Proceedings
    37  
Item 6. Exhibits and Reports on Form 8-K
    37  
Signatures
    39  

1


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

EMULEX CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(in thousands, except share data)
(unaudited)

                     
        September 28,   June 29,
        2003   2003
       
 
Assets
               
Current assets:
               
 
Cash and cash equivalents
  $ 72,181     $ 136,971  
 
Restricted cash
    43,156       9,342  
 
Investments
    228,399       239,302  
 
Accounts and other receivables, net
    52,747       46,678  
 
Litigation settlements receivable
    13,095       13,095  
 
Inventories, net
    12,479       10,998  
 
Prepaid expenses
    5,279       5,516  
 
Deferred income taxes
    28,384       36,330  
 
   
     
 
   
Total current assets
    455,720       498,232  
Property and equipment, net
    34,251       26,585  
Investments
    216,625       234,847  
Goodwill
    397,256       397,256  
Other intangibles, net
    25,617       27,067  
Other assets
    3,262       5,782  
 
   
     
 
 
  $ 1,132,731     $ 1,189,769  
 
   
     
 
Liabilities and Stockholders’ Equity
               
Current liabilities:
               
 
Accounts payable
    20,645       11,298  
 
Accrued liabilities
    15,973       18,806  
 
Accrued litigation settlements
    39,500       39,500  
 
Income taxes payable
    11,368       5,457  
 
   
     
 
   
Total current liabilities
    87,486       75,061  
Convertible subordinated notes
    114,648       208,518  
Deferred income taxes
    3,486       4,260  
 
   
     
 
Total liabilities
    205,620       287,839  
 
   
     
 
Commitments and contingencies (note 7)
               
Subsequent events (note 9)
               
Stockholders’ equity:
               
Preferred stock, $0.01 par value; 1,000,000 shares authorized (150,000 shares designated as Series A Junior Participating Preferred Stock); none issued and outstanding
           
Common stock, $0.10 par value; 240,000,000 shares authorized; 82,616,687 and 82,465,813 issued and outstanding at September 28, 2003, and June 29, 2003, respectively
    8,262       8,247  
Additional paid-in capital
    909,857       907,976  
Deferred compensation
    (2,462 )     (3,159 )
Retained earnings (accumulated deficit)
    11,454       (11,134 )
 
   
     
 
 
Total stockholders’ equity
    927,111       901,930  
 
   
     
 
 
  $ 1,132,731     $ 1,189,769  
 
   
     
 

See accompanying notes to condensed consolidated financial statements.

2


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Income
(in thousands, except per share data)
(unaudited)

                     
        Three Months Ended
        September 28,   September 29,
        2003   2002
       
 
Net revenues
  $ 84,577     $ 70,425  
Cost of sales
    28,327       27,882  
 
   
     
 
   
Gross profit
    56,250       42,543  
 
   
     
 
Operating expenses:
               
 
Engineering and development
    16,344       13,673  
 
Selling and marketing
    4,602       4,664  
 
General and administrative
    3,657       2,746  
 
Amortization of other intangibles
    1,450       1,453  
 
   
     
 
   
Total operating expenses
    26,053       22,536  
 
   
     
 
   
Operating income
    30,197       20,007  
 
   
     
 
Nonoperating income:
               
 
Interest income
    2,498       3,702  
 
Interest expense
    (1,033 )     (1,804 )
 
Gain on repurchase of convertible subordinated notes
    4,665       28,729  
 
Other income (expense), net
    106       (30 )
 
   
     
 
   
Total nonoperating income
    6,236       30,597  
 
   
     
 
Income before income taxes
    36,433       50,604  
Income tax provision
    13,845       18,623  
 
   
     
 
Net income
  $ 22,588     $ 31,981  
 
   
     
 
Net income per share:
               
 
Basic
  $ 0.27     $ 0.39  
 
   
     
 
 
Diluted
  $ 0.27     $ 0.37  
 
   
     
 
Number of shares used in per share computations:
               
 
Basic
    82,541       81,844  
 
   
     
 
 
Diluted
    87,472       89,166  
 
   
     
 

See accompanying notes to condensed consolidated financial statements.

3


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)

                       
          Three Months Ended
          September 28,   September 29,
          2003   2002
         
 
Cash flows from operating activities:
               
Net income
  $ 22,588     $ 31,981  
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
   
Depreciation and amortization of property and equipment
    2,874       2,532  
   
Gain on repurchase of convertible subordinated notes
    (4,665 )     (28,729 )
   
Increase in restricted cash related to litigation settlements
    (39,500 )      
   
Stock-based compensation
    597       846  
   
Amortization of other intangibles
    1,450       1,453  
   
Loss (gain) on disposal of property and equipment
    (1 )     24  
   
Deferred income taxes
    7,172       16,918  
   
Tax benefit from exercise of stock options
    751       287  
   
Provision for doubtful accounts
    34       56  
   
Changes in assets and liabilities:
               
     
Accounts and other receivables
    (6,103 )     (4,318 )
     
Inventories
    (1,481 )     (3,543 )
     
Prepaid expenses and other assets
    755       749  
     
Accounts payable
    9,347       3,938  
     
Accrued liabilities
    (2,724 )     (1,026 )
     
Income taxes payable
    5,911       1,371  
 
   
     
 
 
Net cash provided by (used in) operating activities
    (2,995 )     22,539  
 
   
     
 
Cash flows from investing activities:
               
Net proceeds from sale of property and equipment
    6        
Additions to property and equipment
    (10,545 )     (2,358 )
Decrease in restricted cash related to the construction escrow account
    5,686       284  
Purchases of investments
    (114,918 )     (228,771 )
Maturities of investments
    144,043       159,139  
 
   
     
 
 
Net cash provided by (used in) investing activities
    24,272       (71,706 )
 
   
     
 
Cash flows from financing activities:
               
Proceeds from issuance of common stock under stock option plans
    1,245       181  
Repurchase of convertible subordinated notes
    (87,312 )     (104,169 )
 
   
     
 
 
Net cash used in financing activities
    (86,067 )     (103,988 )
 
   
     
 
Net decrease in cash and cash equivalents
    (64,790 )     (153,155 )
Cash and cash equivalents at beginning of period
    136,971       282,561  
 
   
     
 
Cash and cash equivalents at end of period
  $ 72,181     $ 129,406  
 
   
     
 
Supplemental disclosures:
               
Cash paid during the period for:
               
 
Interest
  $ 1,826     $ 3,052  
 
Income taxes
    11       502  

See accompanying notes to condensed consolidated financial statements.

4


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements

1.   Summary of Significant Accounting Policies and Basis of Presentation
 
    In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments (which are normal recurring accruals) necessary to present fairly its financial position as of September 28, 2003, and June 29, 2003, and its condensed consolidated statements of income for the three months ended September 28, 2003, and September 29, 2002, and its condensed consolidated statements of cash flows for the three month periods then ended. Interim results for the three months ended September 28, 2003, are not necessarily indicative of the results that may be expected for the year ending June 27, 2004. The interim financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 29, 2003.
 
    Recently Adopted Accounting Standards
 
    The Emerging Issues Task Force (“EITF”) recently reached a consensus on its tentative conclusions for EITF 00-21, “Revenue Arrangements with Multiple Deliverables.” EITF 00-21 provides accounting guidance for customer solutions where delivery or performance of products, services and/or performance may occur at different points in time or over different periods of time. Companies are required to adopt this consensus for fiscal periods beginning after June 15, 2003. The adoption of EITF 00-21 did not have a material impact on the Company’s financial position, results of operations or liquidity.
 
    In April 2003, the Financial Accounting Standards Board, (“FASB”) issued Statement 149, an amendment of FASB Statement No. 133, “Accounting for Derivative Instruments and Hedging Activities,” which requires prospective application for contracts entered into or modified after June 30, 2003, except for contracts that exist in fiscal quarters that began prior to June 15, 2003, and for hedging relationships designated after June 30, 2003. For existing contracts in fiscal quarters that began prior to June 15, 2003, the provisions of this Statement that relate to Statement 133 implementation issues should continue to be applied in accordance with their respective effective dates. Statement 149 requires that contracts with comparable characteristics be accounted for similarly. The adoption of this pronouncement did not have a material impact on the Company’s financial position, results of operations or liquidity.
 
    In May 2003, the FASB issued Statement 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” Statement 150 establishes standards for classifying and measuring certain financial instruments with characteristics of both liabilities and equity. Statement 150 requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in some circumstances) because that financial instrument embodies an obligation of the issuer. Statement 150 is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective for public companies during the first interim period beginning after June 15, 2003. The adoption of this pronouncement did not have a material impact on the Company’s financial position, results of operations or liquidity.
 
    Stock-Based Compensation
 
    In December 2002, the FASB issued Statement 148, “Accounting for Stock-Based Compensation – Transition and Disclosure.” Statement 148 amends the disclosure requirements in Statement 123, “Accounting for Stock-Based Compensation” for annual periods ending after December 15, 2002, and for interim periods beginning after December 15, 2002. The Company adopted the disclosure provisions of Statement 148 during the three months ended March 30, 2003. Effective for financial statements for fiscal years ending after December 15, 2002, Statement 148 also provides three alternative transition methods for companies that choose to adopt the fair value measurement provisions of Statement 123. Should the Company be required to adopt the fair value measurement provisions of Statement 123 and Statement 148, it would have a material non-cash impact on the Company’s results of operations. However, the Company has no plans to adopt the fair value measurement provisions of Statement 123 unless required to under new accounting standards and, as such, the adoption of Statement 148 did not have a material impact on the Company’s financial position, results of operations or liquidity.

5


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements

    The Company accounts for its stock-based awards to employees using the intrinsic value method under Accounting Principles Board (“APB”) Opinion No. 25 and related Interpretations. Stock-based awards to non-employees, if any, are recorded using the fair value method. Had the Company determined compensation cost based on the fair value at the grant date for all its stock options under Statement 123, the Company’s net income would have been the pro forma amounts indicated below:

                   
      Three Months Ended
     
      September 28,   September 29,
      2003   2002
     
 
      (In thousands, except per share data)
Net income as reported
  $ 22,588     $ 31,981  
Add: Total employee stock-based compensation expense included in net income as reported, net of related tax effects
    596       845  
Deduct: Total employee stock-based compensation expense determined under fair value method for all awards, net of related tax effects
    (7,976 )     (9,263 )
 
   
     
 
Pro forma net income
  $ 15,208     $ 23,563  
 
   
     
 
Pro forma net income per share
               
 
Basic – as reported
  $ 0.27     $ 0.39  
 
   
     
 
 
Basic – pro forma
  $ 0.18     $ 0.29  
 
   
     
 
 
Diluted – as reported
  $ 0.27     $ 0.37  
 
   
     
 
 
Diluted – pro forma
  $ 0.18     $ 0.28  
 
   
     
 

    The fair value of each option granted during the three months ended September 28, 2003, and September 29, 2002, was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

                 
    Three Months Ended
   
    September 28,   September 29,
    2003   2002
   
 
Risk-free interest rate
    2.3 %     2.3 %
Stock volatility
    117.7 %     98.5 %
Dividend yield
    0.0 %     0.0 %
Average expected lives (years)
    2.6       3.7  
Weighted-average fair value per option granted
  $ 15.64     $ 11.51  

    The Black-Scholes model, as well as other currently accepted option valuation models, was developed to estimate the fair value of freely-tradable, fully-transferable options without vesting restrictions, which significantly differ from the Company’s stock option plans. These models also require highly subjective assumptions, including future stock price volatility and expected time until exercise, which greatly affect the calculated fair value on the grant date.

6


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements

2.   Inventories
 
    Inventories, net, are summarized as follows:

                 
    September 28,   June 29,
    2003   2003
   
 
    (in thousands)
Raw materials
  $ 6,004     $ 3,802  
Finished goods
    6,475       7,196  
 
   
     
 
 
  $ 12,479     $ 10,998  
 
   
     
 

    Starting in late September 2001, some of the Company’s major customers made announcements that general economic conditions, exacerbated by the increase in economic uncertainty in the aftermath of the terrorist events of September 11, 2001, were having a negative impact on their financial results. The announcements made, and forecasts received, indicated deteriorating demand for the Company’s one gigabit per second (“Gbps”) products as these customers were expected to migrate to two Gbps products for future purchases. As a result, the Company recorded an excess and obsolete inventory charge totaling $13.6 million during the three months ended September 30, 2001. After initially recording its one Gbps reserve in September 2001, the Company has subsequently reduced this reserve by a total of $8.7 million through September 28, 2003, as previously-reserved inventory has been sold. Overall, the Company has been able to recover a significant portion of this reserved inventory that was not expected based on the Company’s forecasts and the forecasts received from its customers when this excess and obsolete inventory charge was recorded. In addition to the sale of some of this previously-reserved product, the Company has also scrapped $3.4 million of this reserved inventory and negotiated and paid cancellation charges of $0.2 million through September 28, 2003, related to this excess and obsolete inventory charge since it was initially recorded. As of September 28, 2003, the remaining reserve for one Gbps products was $1.3 million. However, as with all inventory, the Company regularly compares forecasted demand for its one Gbps products against inventory on hand and open purchase commitments and accordingly, the Company may have to record reductions to the carrying value of excess and obsolete inventory if forecasted demand decreases. As of September 28, 2003, the Company had unreserved one Gbps inventory on hand of approximately $0.9 million.
 
3.   Goodwill and Other Intangibles
 
    Goodwill and other intangibles, net, are as follows:

                   
      September 28,   June 29,
      2003   2003
     
 
      (in thousands)
Intangible assets not subject to amortization:
               
 
Goodwill
  $ 397,256     $ 397,256  
 
   
     
 
Intangible assets subject to amortization:
               
 
Core technology and patents
  $ 40,600     $ 40,600  
 
Accumulated amortization, core technology and patents
    (14,983 )     (13,533 )